SciELO - Scientific Electronic Library Online

 
vol.36 número1Commentary: Ethical considerations for COVID-19 researchTorsade de pointes caused by hydroxychloroquine use in a patient with a severe form of COVID-19 índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Southern African Journal of Critical Care (Online)

versão On-line ISSN 2078-676X
versão impressa ISSN 1562-8264

South. Afr. j. crit. care (Online) vol.36 no.1 Pretoria Jan./Jul. 2020

http://dx.doi.org/10.7196/sajcc.2020.v36i1.452 

EDITORIAL

 

Paediatric critical care during the COVID-19 pandemic

 

 

The COVID-19 pandemic has resulted in careful review of patients affected and resource distribution, with particular emphasis on intensive care unit (ICU) facilities. In comparison with adults, evidence from China, Canada and the USA suggests a lesser COVID-19 burden on children, as well as improved outcomes.[1-4] Less than 5% of all positive SARS-CoV-2 cases are <19 years old, as described in a systematic review of 45 studies.[5]

It is estimated that 5% of infected adults will need ICU admission, whereas ~10% of infants and 5% of older children will only require supplemental oxygen. Around 0.6% of children are expected to develop acute respiratory distress syndrome (ARDS).[4] Furthermore, a review of all SARS-CoV-2 infected paediatric ICU (PICU) admissions in 46 Canadian and USA PICUs described 48 admissions with a median length of PICU stay of 5 days and mortality rate of 4%. Of the cohort, the need for invasive ventilation, multi-organ failure support and extracorporeal life support was 38%, 23% and 2%, respectively.[6]

Currently, there are no data on PICU COVID-19 admissions in low- and middle-income countries (LMICs), nor on the effect on immunosuppressed or malnourished children. Given the under-5 pneumonia mortality rate of LMICs compared with high-income countries (200 v. 3 per 100 000), concerns exists that COVID-19 pneumonia may have a larger impact on children in LMICs.[7-

Several paediatric critical care COVID-19-related concerns have developed in the South African (SA) context. Firstly, PICU bed capacity is underrepresented. In 2007, a national audit demonstrated that only 19.6% of the total ICU beds in SA were for children.[8] Since the audit, there has been very little increase in the number of PICU beds nationally. The inequity of paediatric critical care resources is highlighted when considering that the paediatric population constitutes 34% of the total population.[9] Moreover, under-5 mortality in SA is ~42 deaths per 1 000 live births, and remains higher than other middle-income countries such as Brazil and Cuba.[10,11]

The seasonal winter surge period increases PICU bed pressure owing to increased burden of viral and bacterial pneumonias. During this period, elective surgeries are often cancelled to accommodate emergency admissions. Currently, the surge period coincides with the COVID-19 pandemic, and the anticipated increase of 0.6% of COVID-19-related ARDS admissions will overrun the SA paediatric critical care capacity. Given the limited PICU resources and the overall good prognosis of paediatric patients, including those with severe COVID-19, it is imperative that PICU beds remain ring-fenced for children, and not redistributed to adult critical care services.

A second discussion point is triage and resource allocation for critically ill paediatric patients. The guidelines in the 'Allocation of scarce critical care resources during the COVID-19 public health emergency in South Africa' document from the Critical Care Society of Southern Africa (CCSSA) are not applicable to children, as the clinical frailty scale and sequential organ failure assessment (SOFA) score are not validated in children.[12 Considering the special needs of children during this pandemic, a SA Paediatric Critical Care working group was established. Given the good outcomes of children, the group's consensus statement[13] is that triage and resource allocation during the COVID-19 pandemic should continue as per usual local PICU practice. We support the principle of paediatric critical care resource allocation to children who have the best long-term prognoses and will benefit from PICU treatment. Thus, the majority of SARS-CoV-2-infected children will unequivocally meet PICU admission criteria.

Thirdly, some controversy exists around the use of non-invasive ventilation (NIV) and high-flow nasal cannula (HFNC) in patients with COVID-19. NIV and HFNC are discouraged in the CCSSA document 'Critical care management of patients confirmed with COVID-19' as well as the Department of Health's guide on 'Management of children with suspected or confirmed COVID-19 infection'.[14,15] Many children presenting with severe respiratory symptoms during the winter season will have viral pneumonia other than COVID-19 pneumonia. It is impossible to distinguish between different pneumonia aetiologies on clinical grounds alone. NIV and HFNC reduce the need for intubation and PICU admission.[16] To deny NIV and HFNC to children in respiratory distress while waiting for confirmatory tests will have disastrous consequences. SA simply does not have the PICU capacity to admit all children with severe respiratory distress, as suggested in the above documents.

Concerns about NIV and HFNC are based on the potential for aerosolisation and subsequent risk to staff. Internationally, many adult and paediatric critical care societies, as well as the World Health Organization (WHO), recommend all forms of NIV and HFNC for SARS-CoV-2-infected patients, provided the staff wear appropriate personal protective equipment (PPE) and patients are isolated.[17-20] In children, NIV and HFNC flow rates are low compared with adults. Aerosolisation risks are therefore lower, with estimated dispersion of only a few centimetres.[21,22] Furthermore, there is no conclusive evidence to suggest that HFNC poses a greater risk than other forms of NIV, and wearing a surgical mask over the interface limits aerosol dispersion.[23]

The updated National Institute for Communicable Diseases' 'Clinical management of suspected or confirmed COVID-19 disease' guideline (version 4) recommends HFNC and NIV only in PICU. This should be provided in an isolation room, ideally with negative pressure and with a barrier device over the child such as a perspex box.[24] SA does not have the PICU capacity to admit all children on HFNC or NIV, and has very limited PICU isolation facilities. The consensus statement from the SA Paediatric Critical Care working group[13] is to offer NIV to all children in severe respiratory distress, if available. Children on NIV and HFNC should be isolated in single rooms and, if not available, cohorted into open wards with surgical masks over the interface. Limited staff should be allowed in these areas and should wear appropriate PPE.

Most importantly, children have the right to a parent at their bedside during a hospital admission. The WHO advocates against separating parent and child during a COVID-19 illness, in order to minimise adverse emotional implications for the child.[18,25] Children should furthermore be cared for in a child-friendly environment, by staff who are knowledgeable and well trained in holistic paediatric care. The SA Paediatric Critical Care Working Group supports this principle, and does not recommend cohorting COVID-19-positive children together with adult patients.[13]

Optimal primary child healthcare is essential, especially in the face of a health pandemic: food security, routine immunisations and follow-up clinics for children with chronic medical conditions should continue in order to prevent the development of complications. Failing this, many children will potentially come to harm during this COVID-19 pandemic, even without acquiring the infection.

B Rossouw, MB ChB, DTM&H (SA), MMed (Paed), MSc, Cert Critical Care (Paed), Cert Cardiol (Paed), DPC; Paediatric Intensive Care Unit, Department of Paediatrics, Red Cross War Memorial Children's Hospital and University of Cape Town, South Africa. beyra.rossouw@uct.ac.za

M McCulloch, MB BCh, DCH (SA), DTM&H (UK), FRCPCH (UK), FCP (Paed); Paediatric Intensive Care Unit, Department of Paediatrics, Red Cross War Memorial Children's Hospital and University of Cape Town, South Africa. mignon.mcculloch@uct.ac.za

 

References

1. Cruz A, Zeichner S. COVID-19 in children: Initial characterization of the pediatric disease. Pediatrics 2020:2020-0834. https://doi.org/10.1542/peds.2020-0834        [ Links ]

2. Dong Y, Mo X, Hu Y. Epidemiology of COVID-19 among children in China. Pediatrics 2020;145(6):1-10. https://doi.org/10.1542/peds.2020-0702        [ Links ]

3. US Department of Health, Centers for Disease Control and Prevention. Coronavirus disease 2019 in children - United States, February 12 to April 2, 2020. Morb Mortal Wkly Rep 2020;69(14):422-426. https://doi.org/10.15585/mmwr.mm6914e4        [ Links ]

4. Ong JSM, Tosoni A, Kim Y, Kissoon N, Murthy S. Coronavirus disease 2019 in critically ill children: A narrative review of the literature. Pediatr Crit Care Med 2020;(epub 7 April 2020). https://doi.org/10.1097%2FPCC.0000000000002376        [ Links ]

5. Ludvigsson JF. Systematic review of COVID-19 in children show milder cases and a better prognosis than adults. Acta Paediatrica 2020;109:1088-1095. https://doi.org/10.1111/apa.15270        [ Links ]

6. Shekerdemian LS, Mahmood NR, Wolfe KK, et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr 2020;(epub 11 May 2020). https://doi.org/10.1001/jamapediatrics.2020.1948        [ Links ]

7. Ahmed S, Mvalo T, Akech S, et al. Protecting children in low-income and middle-income countries from COVID-19. BMJ Glob Health 2020;5(5):1-3. https://doi.org/10.1136%2Fbmjgh-2020-002844        [ Links ]

8. Bhagwanjee S, Scribante J. National audit of critical care resources in South Africa - unit and bed distribution. S Afr Med J 2007;97(12):1311-1314.         [ Links ]

9. Hall K. Child Gauge 2019: Demography of South Africa's Children. Cape Town: Children's Institute, 2019.         [ Links ]

10. Shung-King M, Lake L, Sanders D, Hendricks M. Child Gauge 2019: Child and Adolescent Helath. Cape Town: Children's Institute, 2019.         [ Links ]

11. Statistics South Africa. Sustainable Development Goals Country Report 2019: South Africa. Pretoria: StatsSA, 2019.         [ Links ]

12. Critical Care Society of Southern Africa. Allocation of scarce critical care resources during the COVID-19 public health emergency in South Africa. https://criticalcare.org.za/wp-content/uploads/2020/05/V2-2020-May-05-Allocation-of-Scarce-Critical-Care-Resources-During-the-COVID-19-Public-Health-Emergency-in-South-Africa-FINAL-.pdf (accessed 10 May 2020).         [ Links ]

13. Paediatric Critical Care Management of Covid-19 Infected Children (Suspected or Proven). https://criticalcare.org.za/wp-content/uploads/2020/06/FINAL-PCCSA-WITH-AFFILIATIONS-1.6.2020pdf4.pdf (accessed 10 June 2020).         [ Links ]

14. National Department of Health. Management of children suspected or confirmed of COVID-19 infection. Pretoria: NDoH, 2020. http://www.health.gov.za/index.php/component/phocadownload/category/635 (accessed 18 May 2020).         [ Links ]

15. Critical Care Society of Southern Africa. Critical care management of patient confirmed with COVID-19. https://criticalcare.org.za/wp-content/uploads/2020/03/CCSSA-COVID-19-ICU-Management-Summary-V01-19March2020.pdf (accessed 25 April 2020).         [ Links ]

16. Franklin D, Schibler A. Nasal high-flow therapy in infants and children. Pediatric Respirol Crit Care Med 2018;2(1):2-6. https://doi.org/10.3389/fped.2019.00426        [ Links ]

17. Kneyber MCJ, Medina A, Alapont VM, et al. Practice recommendations for the management of children with suspected or proven COVID-19 infections from the Paediatric Mechanical Ventilation Consensus Conference (PEMVECC) and the Section Respiratory Failure from the European Society for Paediatric and Neonatal Intensive Care (ESPNIC). https://espnic-online.org/Media/Files/2020-ESPNIC-PEMVECC-COVID-19-practice-recommendations (accessed 20 May 2020).         [ Links ]

18. World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Geneva: WHO, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected (accessed 20 May 2020).         [ Links ]

19. Paediatric Intensive Care Society UK. Paediatric critical care COVID-19 guide. https://picsociety.uk/wp-content/uploads/2020/03/PICS-Covid-19-guidance-v4.0-14Mar2020-1.pdf (accessed 25 April 2020).         [ Links ]

20. Sundaram M, Ravikumar N, Bansal A, et al. Novel coronavirus 2019 (2019-nCoV) infection: Part IIc - respiratory support in the pediatric intensive care unit in resource-limited settings. Ind Pediatr 2020;57:335-342. https://doi.org/10.1007%2Fs13312-020-1786-x        [ Links ]

21. Li J, Fink JB, Ehrmann S. High-flow nasal cannula for COVID-19 patients: Low risk of bio-aerosol dispersion. European Resp J 2020;55(5):2000892. https://doi.org/10.1183%2F13993003.00892-2020        [ Links ]

22. Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: A systematic review. PLoS ONE 2012;7(4):e35797. https://doi.org/10.1371/journal.pone.0035797        [ Links ]

23. Leonard S, Atwood CW, Walsh BK, et al. Preliminary findings on control of dispersion of aerosols and droplets during high-velocity nasal insufflation therapy using a simple surgical mask: Implications for the high-flow nasal cannula. Chest 2020;(epub 2 April 2020). https://doi.org/10.1016/j.chest.2020.03.043        [ Links ]

24. National Institute for Communicable Diseases. Clinical management of suspected or confirmed COVID-19 disease (version 4, 18 May 2020). https://www.nicd.ac.za/wp-content/uploads/2020/05/Clinical-management-of-suspected-or-confirmed-COVID-19-Version-4.pdf (accessed 25 May 2020).         [ Links ]

25. World Health Organization. Mental health and psychosocial considerations during the COVID-19 outbreak. Geneva: WHO, 2020. https://www.who.int/docs/default-source/coronaviruse/mental-health-considerations.pdf (accessed 31 May 2020).         [ Links ]

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons